LMD-10. The role of immune checkpoint inhibitors in leptomeningeal disease: a systematic review

BACKGROUND: Leptomeningeal disease (LMD) is a devastating complication of advanced malignancy with a poor prognosis and limited therapeutic options. Whether immune checkpoint inhibitors (ICIs) alter disease course is unknown. METHODS: We searched PubMed, EMBASE, Scopus, Cochrane, and clinicaltrials....

Descripción completa

Detalles Bibliográficos
Autores principales: Palmisciano, Paolo, Haider, Ali S, Nwagwu, Chibueze D, Wahood, Waseem, Sagoo, Navraj S, Yu, Kenny, Ene, Chibawane I, O’Brien, Barbara J, Cohen-Gadol, Aaron A, El Ahmadieh, Tarek Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351212/
http://dx.doi.org/10.1093/noajnl/vdab071.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351212/
http://dx.doi.org/10.1093/noajnl/vdab071.035

Ejemplares similares